GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: Braftovi® | LGX-818 | LGX818
                                 
                                                         
                            
                            
                            
                                 
                                
                                encorafenib is an approved drug (FDA and EMA (2018)) 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Encorafenib (LGX-818) is an orally available BRAF kinase inhibitor with antineoplastic activity.
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                      
                                     
                                   
                                   
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
Classification ![]()  | 
                                                    |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. EU EMA (2018) | US FDA (2018) | 
IUPAC Name ![]()  | 
                                                        
| methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 9816 | encorafenib | 
Synonyms ![]()  | 
                                                        
| Braftovi® | LGX-818 | LGX818 | 
Database Links ![]()  | 
                                                        |
| Specialist databases | |
                                                                        Reactome Drug
                                                                        
                                                                             
                                                                              
                                                                        
                                                                     | 
                                                                    R-ALL-9657027 | 
                                                                        Reactome Reaction
                                                                        
                                                                             
                                                                              
                                                                        
                                                                     | 
                                                                    R-HSA-6802938 | 
| Other databases | |
| CAS Registry No. | 1269440-17-6 | 
| ChEMBL Ligand | CHEMBL3301612 | 
| DrugCentral Ligand | 5289 | 
| GtoPdb PubChem SID | 249565591 | 
| PubChem CID | 50922675 | 
| Search Google for chemical match using the InChIKey | CMJCXYNUCSMDBY-ZDUSSCGKSA-N | 
| Search Google for chemicals with the same backbone | CMJCXYNUCSMDBY | 
| Search PubMed clinical trials | encorafenib | 
| Search PubMed titles | encorafenib | 
| Search PubMed titles/abstracts | encorafenib | 
| UniChem Compound Search for chemical match using the InChIKey | CMJCXYNUCSMDBY-ZDUSSCGKSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | CMJCXYNUCSMDBY-ZDUSSCGKSA-N | 
| Wikipedia | LGX818 | 
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖| 
                                                                     
                                                                         
                                                                         
                                                                             
                                                                         
                                                                         
                                                                           
                                                                           Encorafenib (links to external site) 
                                                                    
                                                                Cat. No. HY-15605  |